Pharmaceutical Cybersecurity Challenges

Loss of revenue
Reputation damage
Loss of competitive edge
Regulatory intervention

Pharmaceutical, medical device and healthcare manufacturers are migrating from traditional manufacturing to advanced manufacturing – spanning a range of processes, from chemical or biological API (active pharmaceutical ingredients) production to formulation and packaging. This migration is part of the Industrial Internet of Things (IIoT)/Industrie 4.0 revolution, and it introduces new connectivity technologies into pharmaceutical industrial networks. While connectivity is beneficial for controlling the efficiency and quality of production environments, it exposes the industrial (ICS/SCADA) networks to new cyber risks that pose a threat to the company’s operational and business continuity.

The production environments contain the company’s most sensitive information and intellectual property, such as recipes, formulas and manufacturing information – which were the targets of the highly-publicized Dragonfly/Havex campaign. This information must be protected from cyber theft activities that risk the company’s competitive edge. Once these industrial networks are connected to external environments, cybercriminals can target code labeling or track-and-trace systems as part of a counterfeiting operation. In addition, other cyber risks such as process sabotage or potentially-deadly product manipulation threaten manufacturers with severe loss of revenue, damaged reputation, or an FDA intervention.

SCADAfence for the Pharmaceutical Industry

Most of the existing IT security solutions available today are unfit for industrial networks. IT solutions, which are usually designed either for intrusive integration or with active components, can jeopardize operational continuity by adding unnecessary risks. In addition, the solutions are unable to inspect industrial protocols and to profile industrial behavior, and are therefore incapable of maximizing their potential in industrial networks.

SCADAfence’s passive solutions for pharmaceutical companies are designed to reduce operational risks such as downtime, product manipulation and theft of sensitive proprietary information. The company offers a comprehensive solution suite that includes continuous real-time monitoring of the industrial environment as well as lightweight tools designed to automate the security assessment process. The solutions are based on a deep understanding of the needs of pharmaceutical companies, and offer visibility of day-to-day operations, detection of cyber-attacks and forensics tools designed to improve responsiveness.

Industrial Network
and Asset Visibility
Detection of Cyber-Attacks
and Non Malicious Threats
Risk Management
and Predictive Alerts

Want to see how it works?